Introduction
CD41 (or integrin ␣IIb) is a marker of the megakaryocytic lineage and also of other clonogenic progenitors. [1] [2] [3] [4] [5] CD41 marks the onset of murine primitive and definitive hematopoiesis. [5] [6] [7] [8] [9] At embryonic day 7 (E7), yolk sac (YS) primitive erythroid progenitors express low levels of CD41. 7 By E8.25/E9.5, most YS definitive hematopoietic progenitors express CD41 to high levels, 7 and definitive hematopoietic progenitors in the intraembryonic para-aortic splanchnopleura or aorta-gonad-mesonephros (AGM) region also express CD41. 5, [7] [8] [9] These embryonic CD41 ϩ hematopoietic cells possess no endothelial potential. 10, 11 Immunostainings show CD41 ϩ hematopoietic cells within YS blood islands, 7, 8, 12 intra-aortic clusters, [12] [13] [14] and attached to vessel walls of the placenta labyrinth. 15, 16 Real-time vital imaging demonstrates that rare phenotypically defined hematopoietic stem cells (HSCs) become CD41 ϩ as soon as they emerge from the aortic endothelium. 13 Based on these findings, CD41 has been suggested as a marker expressed by nascent HSCs, denoting the onset of hematopoietic fate. However, it is still unclear whether HSCs express CD41 throughout development.
HSCs (as defined by the ability to long-term, high-level, multilineage repopulate the hematopoietic system of irradiated adult mouse recipients) start to be detected at E10.5 in the aorta and vitelline/umbilical arteries [17] [18] [19] [20] and emerge from hemogenic endothelium. 13, 21, 22 HSCs are also in the YS, placenta, and fetal liver (FL) beginning at E11.5. 23 Only few transplantation data are available for CD41-sorted AGM cells. 24, 25 When sorted in the context of other markers (CD48, CD150, CD45, and endomucin), HSCs were in both CD41 ϩ and CD41 Ϫ fractions. To clarify whether CD41 is a HSC marker during development, we performed a comprehensive analysis of CD41 expression (negative, intermediate, high) on HSCs (during and subsequent to the developmental time in which they are generated) in the various HSC-containing tissues. We show that all E11 AGM HSCs express CD41 to intermediate levels and that expression is time and hematopoietic territory dependent.
Methods

Embryos and cell preparations
Timed matings were set up between males of transgenic mouse line Ln72 26 or Ly6A GFP 17 and wild-type (C57BL/10 ϫ CBA)F1 females; or C57BL6 Ly5.1 males and females. Vaginal plug day is E0. Recipients were (C57BL/10 ϫ CBA)F1 or C57BL6 Ly5.2 (8-10 weeks old). Animals were housed according to institutional guidelines, and procedures were performed in compliance with Standards for Care and Use of Laboratory Animals with approval from the Erasmus MC ethical review board.
E11/E12 AGM and YS, and E12 placenta and E14 FL were dissected and collagenase dissociated (0.125% weight/volume, type 1, SigmaAldrich Chemie) or crushed (FL). Cells were washed, counted, and suspended in phosphate-buffered saline (PBS), 10% fetal calf serum, and penicillin/streptomycin. Cells were stained with antibodies (supplemental Table 1 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article) for 30 minutes on ice in PBS/fetal calf serum/penicillin/streptomycin, washed and stained with Hoechst 33258, before analysis or sorting on FACScan or ArialIII (BD Biosciences).
Hematopoietic assays
In vitro clonogenic analysis was performed on dilutions of sorted cells plated in methylcellulose (M3434; StemCell Technologies). Hematopoietic colonies were counted at day 12.
For in vivo HSC analysis, sorted cells (various cell doses) were intravenously coinjected with 2 ϫ 10 5 wild-type spleen cells into irradiated (9 Gy split-dose, 137 Cs-source) recipients. After 4 months, donor chimerism (Ln72 or Ly6A GFP) was analyzed by semiquantitative polymerase chain The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked ''advertisement'' in accordance with 18 USC section 1734. reaction (PCR). Signal quantitation was by DNA normalization (myogenin) and Ln72 or Ly6A GFP control DNA dilutions. For multilineage repopulation analysis, T, B, erythroid, and myeloid cells were sorted from recipient bone marrow (BM) and spleens after antibody staining (supplemental Table  1 ). Primary recipient BM (2 ϫ 10 6 ) cells were injected into secondary irradiated recipients to assess self-renewal capacity. For the Ly5.2 recipients injected with Ly5.1 cells, percentage chimerism was determined by flow cytometry on blood after erythrocyte lysis (Beckman Coulter) and antibody and 7-amino-actinomycin D staining (supplemental Table 1 ).
Immunostaining
E11 Ly6A GFP embryos were fixed (2% paraformaldehyde/PBS, 4°C, 1-2 hours), cryoprotected (30% sucrose/PBS, 4°C overnight), Tissue Tek embedded, frozen (dry ice), and cryosectioned. Immunohistochemical staining was as described 17 with anti-CD41 purified, anti-rat IgG1 biotin, and streptavidin-Cy5 (supplemental Table 1 ) and detected by laser scanning microscopy.
Results and discussion
Flow cytometric analysis of CD41 expression was performed on cells from E11 and E12 AGM and YS, E12 placenta, and E14 FL. 7 The highest percentage of CD41 int ϩ high cells is found in placenta, compared with AGM, YS, and FL. This is consistent with the high number of hematopoietic progenitors and HSCs in E12 placenta compared with the other tissues as previously described 15, 27, 28 and the high proportion of megakaryocytic lineage (CD41 high ) cells as determined by coexpression of Gp1b␤ (not shown). In all tissues, the frequency of CD41 int cells is greater than that of CD41 high cells.
To test which CD41 fractions contain hematopoietic progenitors, sorted cells were plated in methylcellulose and colonies counted. Hematopoietic progenitors were found almost exclusively in the CD41 int fraction of E11 AGM and YS cells ( Figure 1B,F) . Although the majority of E12 placenta and E14 FL hematopoietic progenitors were present in the CD41 int fractions, some were also CD41 Ϫ (Figure 2B,F) . Together, these data suggest that CD41 expression on hematopoietic progenitors is developmentally regulated and/or dependent on the specific tissue microenvironment. For personal use only. on May 8, 2018 . by guest www.bloodjournal.org From To examine whether HSCs during ontogeny express CD41, each sorted cell fraction from the distinct embryonic tissues was transplanted and donor cell engraftment examined at 4 months after transplantation. As expected, no mice were reconstituted with the CD41 high fraction. E11 AGM HSCs were found exclusively in the CD41 int fraction ( Figure 1C) and were bona fide self-renewing HSCs as shown by high-level, multilineage engraftment of primary and secondary adult recipients ( Figure 1J ). CD41 expression colocalizes with expression of the Ly6A green fluorescent protein (GFP) HSC marker in some cells closely associated with the ventral aortic endothelium ( Figure 1D ), and multilineage selfrenewing HSCs are enriched in the CD41 int Ly6A GFP ϩ fraction (supplemental Figure 1A-B) . These data indicate, together with previous live imaging data, 13 that CD41 is a marker for the earliest emerging aortic HSCs as they are transiting from endothelial to hematopoietic fate. In contrast, all E12 AGM HSCs were restricted to the CD41 Ϫ fraction (Figure 1I ), suggesting that CD41, as an AGM HSC marker, is developmentally time dependent. This is consistent with the data of McKinney-Freeman et al 25 showing that, at E11.5, AGM HSCs are in both CD41 ϩ and CD41 Ϫ (CD150 Ϫ CD48 Ϫ ) fractions.
CD41 expression on HSCs is not AGM restricted because, when sorted E11 (or E12, not shown) YS cells were transplanted, HSCs were found in both CD41 Ϫ and CD41 int fractions ( Figure 1G ). However, in E12 placenta ( Figure 2C ,H) and E14 FL ( Figure 2G,I ), HSCs were exclusively in the CD41 Ϫ fraction. The presence of HSCs in the E12.5 placenta CD41 ϩ fraction was previously reported, but, as stated by the authors, this was probably because of contaminating CD41 Ϫ cells. 25 At E11.5, no repopulation was found with either the CD41 int or CD41 Ϫ placenta cell fractions (n ϭ 2) because of the extremely low HSC frequency at this time point in the placenta. Thus, we cannot conclude whether the first placental HSCs are CD41 expressing. Immunostainings of E11 FL sections (and flow cytometric analysis of E14 FL) show no overlap in expression of CD41 and Ly6A GFP ( Figure 2D ; supplemental Figure 1C-D) . Thus, CD41 is expressed on HSCs in a timedependent manner. CD41 expression now adds a further possibility for HSC enrichment during development when used in combination with other known HSC markers (Ly6A, c-kit, CD45, CD34, and CD150; supplemental Figures 1-2) .
CD41 as a marker of the earliest HSCs generated in the AGM, together with the finding that some YS HSCs are CD41 expressing, may indicate HSC generation in the YS or HSC migration from the early AGM. CD41 expression on HSCs is lost with developmental time and HSC amplification in placenta, and FL is independent of 
